| P2093 | author name string | Glynis Scott | |
| | Alex Fricke | |
| | Ihsin Kuo | |
| | Laurel Stevens | |
| | Lindy McClelland | |
| | Magali Williamson | |
| P2860 | cites work | Interplay between scatter factor receptors and B plexins controls invasive growth | Q24295561 |
| | Semaphorin 4D/plexin-B1 induces endothelial cell migration through the activation of PYK2, Src, and the phosphatidylinositol 3-kinase-Akt pathway | Q24311648 |
| | Sema4D/plexin-B1 activates GSK-3beta through R-Ras GAP activity, inducing growth cone collapse | Q24550822 |
| | Involvement of CD100, a lymphocyte semaphorin, in the activation of the human immune system via CD72: implications for the regulation of immune and inflammatory responses | Q28189775 |
| | Functional regulation of semaphorin receptors by proprotein convertases | Q28203827 |
| | Plexin B regulates Rho through the guanine nucleotide exchange factors leukemia-associated Rho GEF (LARG) and PDZ-RhoGEF | Q28218379 |
| | The semaphorin 4D receptor controls invasive growth by coupling with Met | Q28219215 |
| | Met, metastasis, motility and more | Q28235183 |
| | Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis | Q28295920 |
| | Sema4D induces angiogenesis through Met recruitment by Plexin B1 | Q28301113 |
| | Plexin-B1 mutations in prostate cancer | Q30480866 |
| | Plexins, semaphorins, and scatter factor receptors: a common root for cell guidance signals? | Q33819069 |
| | Functional map and domain structure of MET, the product of the c- met protooncogene and receptor for hepatocyte growth factor/scatter factor | Q34267718 |
| | Plexins: axon guidance and signal transduction. | Q34409838 |
| | The "Gab" in signal transduction. | Q35082143 |
| | The c-met/HGF receptor in human tumours. | Q35608704 |
| | Plexin B1 is repressed by oncogenic B-Raf signaling and functions as a tumor suppressor in melanoma cells | Q35615400 |
| | To move or not to move? Semaphorin signalling in cell migration | Q35732885 |
| | Semaphorins in cancer | Q35966375 |
| | R-ras as a key player for signaling pathway of plexins. | Q36356581 |
| | GTPases in semaphorin signaling | Q36868896 |
| | Semaphorin signaling in vascular and tumor biology | Q36868935 |
| | Semaphorins and their receptors in lung cancer. | Q37072227 |
| | Deregulation of the Akt pathway in human cancer | Q37089919 |
| | The life of a cell: apoptosis regulation by the PI3K/PKB pathway | Q37289433 |
| | The many faces of semaphorins: from development to pathology | Q37309232 |
| | Cisplatin: a review of toxicities and therapeutic applications | Q37380106 |
| | Neuropilins in tumor biology | Q37400423 |
| | Role of c-Met in cancer: emphasis on lung cancer | Q39839983 |
| | Plexin B1 is downregulated in renal cell carcinomas and modulates cell growth. | Q40012559 |
| | ErbB-2 and met reciprocally regulate cellular signaling via plexin-B1. | Q40048529 |
| | c-Met is a potentially new therapeutic target for treatment of human melanoma | Q40150516 |
| | Structural and functional basis of the serine protease-like hepatocyte growth factor beta-chain in Met binding and signaling | Q40541604 |
| | Tyrosine kinase signal specificity: lessons from the HGF receptor | Q40626260 |
| | Control of invasive growth by the HGF receptor family | Q41640439 |
| | Molecular profiling of the "plexinome" in melanoma and pancreatic cancer | Q41692560 |
| | Expression of the c-Met/HGF receptor in human melanocytic neoplasms: demonstration of the relationship to malignant melanoma tumour progression | Q42389733 |
| | Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1. | Q43890944 |
| | Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases | Q44185238 |
| | The prognostic significance of ulceration of cutaneous melanoma | Q44362550 |
| | Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B. | Q45003993 |
| | The Sema domain of Met is necessary for receptor dimerization and activation | Q46131945 |
| | Phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor growth and prognosis in patients with bladder cancer: correlation with matrix metalloproteinase-2 and -7 and E-cadherin | Q46176116 |
| | Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis. | Q52183100 |
| | Plexin C1, a receptor for semaphorin 7a, inactivates cofilin and is a potential tumor suppressor for melanoma progression. | Q54790387 |
| | c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype | Q77583076 |
| | Poor outcome in estrogen receptor-positive breast cancers predicted by loss of plexin B1 | Q79819362 |
| | Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells | Q80595236 |
| | R-Ras fills another GAP in semaphorin signalling | Q81368938 |
| | The use of sequential serial sectioning of thin melanomas in determining maximum Breslow depth | Q81444186 |
| | Soluble CD100 functions on human monocytes and immature dendritic cells require plexin C1 and plexin B1, respectively | Q81475161 |
| | Loss of Plexin B1 is highly prognostic in low proliferating ER positive breast cancers--results of a large scale microarray analysis | Q82828740 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1636-1645 | |
| P577 | publication date | 2010-02-18 | |
| P1433 | published in | Journal of Investigative Dermatology | Q3186921 |
| P1476 | title | Plexin B1 suppresses c-Met in melanoma: a role for plexin B1 as a tumor-suppressor protein through regulation of c-Met | |
| P478 | volume | 130 | |